中国医师杂志
中國醫師雜誌
중국의사잡지
JOURNAL OF CHINESE PHYSICIAN
2012年
7期
881-884,888
,共5页
严晓梅%胥传海%兰建云%严晓鸥%沈承红%冯一中
嚴曉梅%胥傳海%蘭建雲%嚴曉鷗%瀋承紅%馮一中
엄효매%서전해%란건운%엄효구%침승홍%풍일중
微RNAs/代谢%ras蛋白质类/代谢%癌,非小细胞肺/病理学/代谢
微RNAs/代謝%ras蛋白質類/代謝%癌,非小細胞肺/病理學/代謝
미RNAs/대사%ras단백질류/대사%암,비소세포폐/병이학/대사
MicroRNAs/metabolism%Ras proteins/metabolism%Carcinoma,non-small-cell lung/pathology/metabolism
目的 探讨miRNAlet7( let7)、Ras在非小细胞肺癌中的表达及临床病理学意义.方法 利用原位杂交方法检测let7、免疫组化方法检测Ras在68例非小细胞肺癌(肺癌组)及20例癌旁正常肺组织(对照组)中的表达.结果 let7在肺癌组中的阳性表达率(39.7%)低于对照组(75.0%)(P<0.05)、Ras在肺癌组中的阳性表达率(66.2%)高于对照组(25.0%)(P<0.0l);let7阳性率与患者年龄、性别及肿瘤组织类型、分化程度、分期无关(P>0.05),Ras阳性率与吸烟史、患者性别及肿瘤组织类型有关(P<0.01),与肿瘤分化程度、淋巴结转移及临床分期无关(P>0.05);let7与Ras在非小细胞肺癌组织中表达呈明显负相关(r=-0.627,P<0.01);let7阳性表达组2年生存率明显优于阴性表达组(x2 =4.84,P<0.05);Ras阳性表达与阴性表达组2年生存率差异无统计学意义(P>0.05).结论 let7的低表达、Ras的高表达参与了肺癌的发生发展,let7阳性表达与预后密切相关;Ras可协同参与肺癌的发生发展.
目的 探討miRNAlet7( let7)、Ras在非小細胞肺癌中的錶達及臨床病理學意義.方法 利用原位雜交方法檢測let7、免疫組化方法檢測Ras在68例非小細胞肺癌(肺癌組)及20例癌徬正常肺組織(對照組)中的錶達.結果 let7在肺癌組中的暘性錶達率(39.7%)低于對照組(75.0%)(P<0.05)、Ras在肺癌組中的暘性錶達率(66.2%)高于對照組(25.0%)(P<0.0l);let7暘性率與患者年齡、性彆及腫瘤組織類型、分化程度、分期無關(P>0.05),Ras暘性率與吸煙史、患者性彆及腫瘤組織類型有關(P<0.01),與腫瘤分化程度、淋巴結轉移及臨床分期無關(P>0.05);let7與Ras在非小細胞肺癌組織中錶達呈明顯負相關(r=-0.627,P<0.01);let7暘性錶達組2年生存率明顯優于陰性錶達組(x2 =4.84,P<0.05);Ras暘性錶達與陰性錶達組2年生存率差異無統計學意義(P>0.05).結論 let7的低錶達、Ras的高錶達參與瞭肺癌的髮生髮展,let7暘性錶達與預後密切相關;Ras可協同參與肺癌的髮生髮展.
목적 탐토miRNAlet7( let7)、Ras재비소세포폐암중적표체급림상병이학의의.방법 이용원위잡교방법검측let7、면역조화방법검측Ras재68례비소세포폐암(폐암조)급20례암방정상폐조직(대조조)중적표체.결과 let7재폐암조중적양성표체솔(39.7%)저우대조조(75.0%)(P<0.05)、Ras재폐암조중적양성표체솔(66.2%)고우대조조(25.0%)(P<0.0l);let7양성솔여환자년령、성별급종류조직류형、분화정도、분기무관(P>0.05),Ras양성솔여흡연사、환자성별급종류조직류형유관(P<0.01),여종류분화정도、림파결전이급림상분기무관(P>0.05);let7여Ras재비소세포폐암조직중표체정명현부상관(r=-0.627,P<0.01);let7양성표체조2년생존솔명현우우음성표체조(x2 =4.84,P<0.05);Ras양성표체여음성표체조2년생존솔차이무통계학의의(P>0.05).결론 let7적저표체、Ras적고표체삼여료폐암적발생발전,let7양성표체여예후밀절상관;Ras가협동삼여폐암적발생발전.
Objective To study the expressions of miRNAlet7 and Ras in non-small cell lung cancer ( NSCLC),and their correlations with clinicopathological features and survival time.Methods In-situ hybridization was used to detect the expression of let7,and SP immunohistochemistry to measure HMGA2 in 68 NSCLC cases ( group A) and 20 cases with normal lungs ( group B).Results The positive rate of let7 in group A was lower than that in group B (39.7% vs 63.2% ) ( P <0.05).The positive rate of Ras in group A was higher than that in group B (66.2% vs 25.0% ) ( P <0.01 ).The positive rate of let7 was not related to the age,gender,histological type,cell differentiation,and clinical stages of cancer patients(P >0.05).The positive rate of Ras was related to smoking,sex,and histological type of cancer( P <0.01 ),and was not related to cell differentiation,lymphatic metastasis,and clinical stages of cancer ( P >0.05).There was an obvious negative correlation between let7 and Ras( r =-0.627,P <0.01 ).The 2-year survival rate of let7-positive group was higher than that of the let 7-negative group ( x2 =4.84,P <0.05).No statistically significant difference was found between Ras-positive and-negative groups ( P >0.05 ).Conclusions The lower level of let7 expression,and high level of Ras expression have much to do with the carcinogenesis of NSCLC.The level of let7-positive expression is closely related to prognosis; while Ras may act in cooperativity in the occurrence and development of NSCLC.